Announcements Trials
Browse Landscape

Phase

Phase 1 362Phase 1/2 203Phase 2 71Phase NA 69Phase EARLY_PHASE1 40Phase 3 15Phase 4 3Phase 2/3 3

Status

Completed 10Unknown 4Recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 48Breast 36Genitourinary 30Lymphoid 20Other hematologic neoplasm 18Thoracic 17CNS 14Gynecologic 12Endocrine 10Plasma cell 9Head & Neck 9Dermatologic 7Classical hematology 7Tumor-Agnostic 5Other 5NET 4Myeloid 4Other solid neoplasm 3Sarcoma 2Other neoplasm 1

Conditions

Solid Tumors 1Solid Tumor 1Advanced Solid Tumor 1

Interventions

ribociclib 1encorafenib 1binimetinib 1Immune Checkpoint Inhibitors 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Other solid neoplasm × Clear all
NCT05203172 2026-04-07

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Pfizer

Phase 4 Recruiting
46 enrolled
Other solid neoplasm

Solid Tumors

NCT05525767 2025-12-11

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

Hebei Medical University Fourth Hospital

Phase 4 Recruiting
75 enrolled
Other solid neoplasm

Solid Tumor

NCT06408688 2024-12-27

ISCA-CHECK

University Hospital, Basel, Switzerland

Phase 4 Recruiting
100 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡